{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The O-GlcNAc modification protects against protein misfolding and aggregation in neurodegenerative disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"
    },
    "path": "tau/ryan2019.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "00fa4aec3d428106c63f45b548e3e8b5",
      "line": 82,
      "relation": "increases",
      "source": 67,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "2aabe86ad671c5928ec3d20dc7aa1484",
      "line": 90,
      "relation": "increases",
      "source": 67,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "337a2f1a2a627a24e04f87a70665be09",
      "line": 425,
      "relation": "decreases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "f35f3679c8a65aeefa1701defc49f4e6",
      "line": 509,
      "relation": "decreases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "ca8ceeb0ae61651e2a342faedb1610bb",
      "line": 426,
      "relation": "negativeCorrelation",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "b7a6e646253e70cd65be7f8c5f1135b7",
      "line": 508,
      "relation": "increases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "60da712945989807549c2a40c1d22ead",
      "line": 510,
      "relation": "decreases",
      "source": 67,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "22cc82e02717b10b63fcd4283989e5b4",
      "line": 91,
      "relation": "association",
      "source": 86,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "aab969fb7cb91892ef43cf3cd4954023",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 86,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "85c98ee6d0c11ea49f872c90270070fa",
      "line": 143,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "20ebb67a04641b3c704b68983fc7a58a",
      "line": 144,
      "relation": "association",
      "source": 86,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "47b454139c817141bbef6eb156153b95",
      "line": 152,
      "relation": "association",
      "source": 86,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "027ed03488fa1687a2f1dccc939f2213",
      "line": 446,
      "relation": "association",
      "source": 86,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "2219e216c67d352d32256450e1c1d61a",
      "line": 447,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 14
    },
    {
      "key": "a03a85a31cf85a6f75a52a2037c38311",
      "relation": "hasVariant",
      "source": 85,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The addition and removal of OGlcNAc onto protein substrates is governed entirely by two ubiquitously expressed enzymes: O-GlcNAc transferase [EC 2.4.1.255] (OGT) and O-GlcNAc hydrolase [EC 3.2.1.169] (OGA) respectively (see Figure 2).",
      "key": "9c4df3cb38a3e544616ffaeacad76748",
      "line": 83,
      "relation": "increases",
      "source": 66,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "609f2bb312767bf45131293ba12aadad",
      "line": 143,
      "relation": "negativeCorrelation",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "fcec3cb062cbaef4fd1c9ab8a24fa2f1",
      "line": 116,
      "relation": "association",
      "source": 66,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "d7536beb8afd3565c83ae327598f086f",
      "line": 340,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "5fd736d7cfe045a930f74f7e4850c4f7",
      "line": 344,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 49
    },
    {
      "annotations": {
        "CellLine": {
          "Neuro-2a cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "2fc6a82bb7bf0a5970261fe83d316aca",
      "line": 372,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Inactivation of OGA dramatically promoted HD model toxicity while removal of OGT worked to alleviate toxicity",
      "key": "35ccd22f1a923d98d40f1da4770d5f2b",
      "line": 685,
      "relation": "decreases",
      "source": 66,
      "subject": {
        "modifier": "Activity"
      },
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "OGT-mediated transfer of O-GlcNAc onto proteins is therefore closely tied to cellular glucose concentrations, though notably glucosamine and GlcNAc may also be recycled via salvage pathways",
      "key": "efa6219f680a1f8dc5a99ffaff73976e",
      "line": 91,
      "relation": "association",
      "source": 26,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, it has been found that a decreased availability of glucose invokes a considerable reduction in the level of O-GlcNAc present in the mouse brain",
      "key": "03d9b55b3ad45afc114b61078eda1709",
      "line": 101,
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, hyperglycaemic conditions yield increased levels of O-GlcNAc",
      "key": "8eec5c2e95ebbe8caeee7c8fb4a7dc22",
      "line": 109,
      "relation": "increases",
      "source": 114,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Knockout studies in mice suggest OGA plays a critical role in brain development",
      "key": "534f266c27857351fe09bde6d779949f",
      "line": 116,
      "relation": "association",
      "source": 25,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "9f0417749334fbffedd5b5adeed62682",
      "line": 125,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 66
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "7a7b0fc1e4f92df84523c45b4ed1cae0",
      "line": 587,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 66
    },
    {
      "annotations": {
        "CellStructure": {
          "Lysosomes": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Though highly potent, PUGNAc (1, Scheme 1) was found to also effectively inhibit human lysosomal hexosaminidase, limiting its utility",
      "key": "37d82eef9da868b72d72a734f9440eda",
      "line": 127,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 19
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "955bfd79e0ba17a26bb084184b7c1f44",
      "line": 588,
      "relation": "increases",
      "source": 21,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "54f2df43b560eed1c9035638c0d6cbea",
      "line": 625,
      "relation": "increases",
      "source": 21,
      "target": 52
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "d20a196d3858d81cc0442a42f7a56258",
      "line": 589,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 47
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of SH-SY5Y neuroblastoma with PUGNAc, an OGA inhibitor, has increased levels of O-GlcNAc modified APP and secretion of sAPPÎ± while decreasing secretion of AÎ²40",
      "key": "00063414dbacd9ed5dc235059953525e",
      "line": 590,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 21,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "1ea9e3a5e92cee7788e1a873a2f6f449",
      "line": 617,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "trans-Golgi network",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "plasma membrane",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 21,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PUGNAc treatment increased the rate of APP trafficking to the plasma membrane from the trans- Golgi network and decreased the rate of APP endocytosis",
      "key": "c691b41d386956e542263acb1482e26c",
      "line": 618,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 21,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "3fe277ccb6178958ba02f06f5120122b",
      "line": 628,
      "relation": "increases",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G is able to permeate the blood-brain barrier and is highly selective for human OGA",
      "key": "96016b3bbf8012d250546e56f7018f08",
      "line": 135,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Brain",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 20,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G is able to permeate the blood-brain barrier and is highly selective for human OGA",
      "key": "8a4ed81b752a3e867b45b347bfaecc2b",
      "line": 136,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "11e02a26a4c219e4af410b3ad0c45dea",
      "line": 339,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "3906f3c124c5ef606d516bdb15a4c5be",
      "line": 341,
      "relation": "increases",
      "source": 20,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "7ba1d40e6a5f904af18486f5d4c989f4",
      "line": 342,
      "relation": "increases",
      "source": 20,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment increased levels of monomeric ASyn after 7 days by 50% relative to the control.",
      "key": "8673c4a8eefca793396f07d6c860eb11",
      "line": 353,
      "relation": "increases",
      "source": 20,
      "target": 68
    },
    {
      "annotations": {
        "CellLine": {
          "PC-12 cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "89a3f2149552d86ff8a04f51a6fefa60",
      "line": 495,
      "relation": "decreases",
      "source": 20,
      "target": 63
    },
    {
      "annotations": {
        "CellLine": {
          "PC-12 cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Acute treatment with Thiamet-G effectively decreased phosphorylation of tau at pathologically relevant sites, Thr231 and Ser396, in PC-12 cells",
      "key": "cb2206dd4b77c3439e7c535cfe9ecc4f",
      "line": 496,
      "relation": "decreases",
      "source": 20,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G was able to decrease effectively aggregation in tau-BiFC cells, even after treatment with BZX2, an OGT inhibitor reported to downregulate O-GlcNAcylation and promote phosphorylation and aggregation",
      "key": "09ddcbcc6435d3115fbe8d4258f4d634",
      "line": 507,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "794b2f8a8e727195f3bfd91c25a793bf",
      "line": 534,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "e42f6010f94f5980f241a329984b8195",
      "line": 554,
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "e2dabf4f53dc487d8a3180eb5d5ebcfc",
      "line": 565,
      "object": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 20,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "553f12e6a581acc7037125653f8939e3",
      "line": 520,
      "relation": "decreases",
      "source": 20,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "d530433b7e30e86f162f7786445a587f",
      "line": 521,
      "relation": "decreases",
      "source": 20,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G remains effective in vivo, efficiently reducing phosphorylation at Thr231, Ser396 and Ser422 in both rat cortex and hippocampus.",
      "key": "679e9d950038212e8d13f7cf8f7460d8",
      "line": 522,
      "relation": "decreases",
      "source": 20,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "bf1ac62099f6495cc56cf46624d8d9af",
      "line": 533,
      "relation": "increases",
      "source": 20,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "54b7259936ec561180bfa0be3c9d9d44",
      "line": 548,
      "relation": "increases",
      "source": 20,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Long-term treatment of JNPL3 tau tg mice with Thiamet- G increased levels of O-GlcNAc modified tau while decreasing levels of tau aggregates and neuron death",
      "key": "64d19beadc139195b112f127e5d3ebc1",
      "line": 535,
      "relation": "decreases",
      "source": 20,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "c9e54d8f6773e27b0dd21961854675fb",
      "line": 549,
      "relation": "decreases",
      "source": 20,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "3e8af112661892897e1f2690d8b097b0",
      "line": 550,
      "relation": "decreases",
      "source": 20,
      "target": 95
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "4e7c73168fa114a6fcd5856ccb3d74cf",
      "line": 551,
      "relation": "decreases",
      "source": 20,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "8f8bc24e9af5105fe535fafe453b48ee",
      "line": 552,
      "relation": "decreases",
      "source": 20,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In rTg4510 mice, acute treatment led to increased tau O-GlcNAcylation, reduced tau phosphorylation at epitopes S202/S205, S626, S356 and S396 (notably excluding S400), besides reducing levels of pathological tau aggregation",
      "key": "2d961a50a133d82207720b28308e1949",
      "line": 553,
      "relation": "causesNoChange",
      "source": 20,
      "target": 94
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent studies on rTg4510 mice found their chronic treatment reduced pathological tau in the brain besides total tau in the CSF also.",
      "key": "d0140e2aa17d93bf9ef40bc6cc85d743",
      "line": 566,
      "object": {
        "location": {
          "name": "Cerebrospinal Fluid",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 20,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "e62cb9c7e5ab18f68b6fb7d6f9060fea",
      "line": 637,
      "relation": "increases",
      "source": 20,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "3f720211d14a654966ba4d25618d827a",
      "line": 638,
      "relation": "decreases",
      "source": 20,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "60ca2af761315c6f1641120d23ea9a4a",
      "line": 639,
      "relation": "decreases",
      "source": 20,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "58650796cbc88f5ff7fd70703292954a",
      "line": 641,
      "relation": "causesNoChange",
      "source": 20,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, increased levels of O-GlcNAc via pharmacological OGA inhibition have frequently led to alterations in protein phosphorylation levels",
      "key": "048b1dafaaf7a56006444e6648d85289",
      "line": 144,
      "relation": "association",
      "source": 32,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "A proteomics study conducted by Hart and co-workers found that globally elevated OGlcNAcylation levels lowered phosphorylation at 280 sites while actually increasing it at 148 other sites",
      "key": "924f93b37b9e5ee52d62d9aebefd50e8",
      "line": 152,
      "relation": "association",
      "source": 32,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "d7e8410e373d7347a9d8c3bd0aa43617",
      "line": 161,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "820ecbfbc99dabfeae82973da23e3ff6",
      "line": 186,
      "relation": "association",
      "source": 111,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "e6b7667c2240e07313b52507bb5f11b6",
      "line": 243,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 111,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "f3aad547e832068495eaf13de4bf7e72",
      "line": 309,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 111,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "6460d007ce5b4e8a1955f8393e17aafe",
      "line": 161,
      "relation": "positiveCorrelation",
      "source": 6,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "c7266647917fe7633935b7e29405acb4",
      "line": 162,
      "relation": "negativeCorrelation",
      "source": 6,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Substantia Nigra": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "PD is characterised by the progressive degeneration of dopamine-producing neurons in the substantia nigra, resulting in impaired motor function",
      "key": "ca1f102e72537569ca13ed44f79d58b7",
      "line": 162,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "negativeCorrelation",
      "source": 29,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "a2c13c5af30bf0e5c42fd16d9dfaf055",
      "line": 170,
      "relation": "decreases",
      "source": 29,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "d00c9c97a98fa53a291c619ca7e6ad58",
      "line": 171,
      "relation": "decreases",
      "source": 29,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "This impairment manifests compromised postural reflexes, muscular rigidity and bradykinesia in patients.",
      "key": "6351e4337396bae0727429373ae78def",
      "line": 172,
      "relation": "decreases",
      "source": 29,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Point mutations in the ASyn gene (SNCA) underlie familial disorders with parkinsonian characteristics, suggesting a pathogenic role for ASyn accumulation",
      "key": "c1571c2377e8c8510dd7fa1ce34292f2",
      "line": 179,
      "relation": "increases",
      "source": 80,
      "target": 111
    },
    {
      "key": "f330221a26c90e449c53889c40f0191c",
      "relation": "hasVariant",
      "source": 68,
      "target": 80
    },
    {
      "key": "c6121f5280d6c5a591acb147a6a7393b",
      "relation": "partOf",
      "source": 68,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "3169ba6b936ef2af8cc78a9de5160f6a",
      "line": 195,
      "relation": "regulates",
      "source": 68,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "d11d47171b87ef860b8a021ea595898b",
      "line": 197,
      "relation": "association",
      "source": 68,
      "target": 27
    },
    {
      "key": "6caabf974798ac57a30704e2a7902caa",
      "relation": "partOf",
      "source": 68,
      "target": 36
    },
    {
      "key": "54c6a8ab9cbc96aeb692a6d5c2bee4d6",
      "relation": "partOf",
      "source": 68,
      "target": 40
    },
    {
      "key": "3a489e762684bc46f93e2d7df1019b34",
      "relation": "hasVariant",
      "source": 68,
      "target": 72
    },
    {
      "key": "0504ec2d5192b0c293191a15515a9a46",
      "relation": "hasVariant",
      "source": 68,
      "target": 71
    },
    {
      "key": "653c51a06de898b97f90fd094a767376",
      "relation": "hasVariant",
      "source": 68,
      "target": 79
    },
    {
      "key": "d0b259d21fdb57179f3151ed1f421499",
      "relation": "hasVariant",
      "source": 68,
      "target": 73
    },
    {
      "key": "c19fef842ac38bc19a8c260d7cb78f2c",
      "relation": "hasVariant",
      "source": 68,
      "target": 76
    },
    {
      "key": "df00966a3164b9aa47791df6b1f7e2e5",
      "relation": "hasVariant",
      "source": 68,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "4ad75d733aa3ae45708bb491ed770284",
      "line": 283,
      "relation": "increases",
      "source": 68,
      "target": 11
    },
    {
      "key": "0dee524b1aaf21721879ee4d6b62271c",
      "relation": "hasVariant",
      "source": 68,
      "target": 77
    },
    {
      "key": "bf8d2c374c46244c65ab8bbc500e79fd",
      "relation": "hasVariant",
      "source": 68,
      "target": 78
    },
    {
      "key": "a66fb4ba41e5faa463fb7f184ecdd7d0",
      "relation": "hasVariant",
      "source": 68,
      "target": 75
    },
    {
      "key": "f1ec33113c2c3428850f1a9335670b48",
      "relation": "hasVariant",
      "source": 68,
      "target": 69
    },
    {
      "key": "45d6c273173f51b9483564544c5e1529",
      "relation": "hasVariant",
      "source": 68,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The current consensus is that ASyn self-assembly plays a critical role in PD, whether it be a cause or symptom of the complex pathological cascade.",
      "key": "c7d56ba26e3cd513e60813335438387a",
      "line": 186,
      "relation": "association",
      "source": 39,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "7c2aee711974500ce9ff1c27a0e1a200",
      "line": 197,
      "relation": "association",
      "source": 27,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "7429521849e068f5c8e95292b324ab5e",
      "line": 198,
      "relation": "association",
      "source": 27,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Reports suggest ASyn has a role in regulating supply and management of synaptic vesicles,[57] while also possibly regulating neuronal release of dopamine, a neurotransmitter involved in controlling voluntary and involuntary movement",
      "key": "38b4c47bfa805ce8fbe5c401df043e76",
      "line": 198,
      "relation": "association",
      "source": 30,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cell Membrane": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its C-terminal domain) to promote SNARE-complex assembly.",
      "key": "f4cc3f6a9d36504101ca6d6a8abf71c3",
      "line": 206,
      "relation": "increases",
      "source": 36,
      "target": 23
    },
    {
      "key": "d70b09faa7826e6fb46e901d5f862cc2",
      "relation": "partOf",
      "source": 4,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyn binds simultaneously to plasma membrane phospholipids (via its N-terminal domain) and to synaptobrevin-2 (via its C-terminal domain) to promote SNARE-complex assembly.",
      "key": "da1ac8d3203bc9223db5ade537c11774",
      "line": 208,
      "relation": "increases",
      "source": 40,
      "target": 23
    },
    {
      "key": "23b9d2a3bfa7cf68174198b30b4e6ccd",
      "relation": "partOf",
      "source": 83,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It has been suggested that large ASyn aggregates actually work to sequester other harmful conformers, thus acting in a neuroprotective manner.",
      "key": "95f214d58e4ab4d20de4df1da964f34f",
      "line": 214,
      "relation": "decreases",
      "source": 10,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "5850a9e83933c047fa53dcc424180db9",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Notably, cleavages at the ASyn C-terminus typically increase the resultant truncated proteinâs aggregation, as has been demonstrated in vitro and in overexpression experiments",
      "key": "95124bbff593edc848395c7ffba31199",
      "line": 222,
      "relation": "increases",
      "source": 72,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Specifically calpain, a cysteine protease, cleaves soluble ASyn at a number of sites.",
      "key": "184fd09b986b3ffb44386bdc40573177",
      "line": 229,
      "relation": "increases",
      "source": 84,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "cf018da57bf9c81784265e651a555d88",
      "line": 310,
      "relation": "increases",
      "source": 84,
      "subject": {
        "modifier": "Activity"
      },
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "83432ad22d8f2b726d3b5961d61b2ed7",
      "line": 235,
      "relation": "increases",
      "source": 84,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain activity correlates with disease progression in PD mouse models",
      "key": "4ef9f24f36ed2c5800bf398f0af9db49",
      "line": 243,
      "relation": "association",
      "source": 84,
      "subject": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "db3e08bcf91641c116cc79c06d192f9e",
      "line": 309,
      "relation": "association",
      "source": 84,
      "subject": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "143af9446a15b8b5c38968d5e8b83a17",
      "line": 320,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 84,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "efea7d7775516f0b544f9272709c7c99",
      "line": 321,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "causesNoChange",
      "source": 84,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Both the synthetic ASyngT72 and ASyngS87 peptides exhibit strong resistances to cleavage from recombinant calpain, where unmodified ASyn is degraded rapidly",
      "key": "07d84f7a93971a0b7baf7694cc03de4c",
      "line": 322,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 84,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "As mentioned previously, calpain activity correlates well with disease progression in PD mouse models, catalysing the truncation of ASyn into aggregation-prone species",
      "key": "c37a46867e4cb6bcda6aef66b11c4b2b",
      "line": 311,
      "relation": "increases",
      "source": 71,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Calpain also cleaves ASyn fibres to generate C-truncated forms which promote seeded aggregation",
      "key": "26148d8a433190e44c995b1b934b0d3e",
      "line": 236,
      "relation": "increases",
      "source": 46,
      "target": 10
    },
    {
      "key": "ce0cd6b70c8973feb629c953447d3f3a",
      "relation": "hasVariant",
      "source": 45,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An estimated 90% of the proteins constituting ASyn aggregates bear phosphate groups at Ser129, suggesting that ASyn phosphorylation, or at least elevated levels of phosphorylated ASyn, contributes to PD pathogenesis",
      "key": "d608253446e612328bdbb79adc02ecd7",
      "line": 253,
      "relation": "increases",
      "source": 79,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The O-GlcNAc modification has been shown to slow the aggregation rate of ASyn relative to the wild-type.",
      "key": "a39f27a96e19ddb1a4fdc39d7f90394d",
      "line": 260,
      "relation": "decreases",
      "source": 73,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "b1cbe1e6fb3055df72cee1aa8ddf7252",
      "line": 330,
      "relation": "increases",
      "source": 73,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Initially it was found that semisynthetic ASyn bearing an O-GlcNAc unit at Thr72 (ASyngT72) displayed a reduced self-assembling propensity relative to the wild-type during thioflavin T (ThT) fluorescence assay",
      "key": "62f825f5cd30f9c1bbfb48e4df7c374c",
      "line": 269,
      "relation": "decreases",
      "source": 76,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "In fact, ASyngT72 did not form aggregates even after 7 days of incubation",
      "key": "5227bd9b4d129d811b6b5855cf9a0dec",
      "line": 275,
      "relation": "decreases",
      "source": 76,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "fb19c8493412d5eb3ac4dfc6b17c5d32",
      "line": 282,
      "relation": "increases",
      "source": 76,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "TEM found semisynthetic ASyngS87 forms shorter fibrils than the wildtype, while ASyngT72 formed only small, broken fibrils",
      "key": "3798260b4f5402e09fb96d938576a873",
      "line": 281,
      "relation": "increases",
      "source": 74,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "1d35934acbb0cab7d145d346d937f60f",
      "line": 290,
      "relation": "increases",
      "source": 77,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "a2aeed311fd74e090784c90f6c0760a3",
      "line": 291,
      "relation": "increases",
      "source": 78,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "ASyngT75 and ASyngT81 formed rare, highly irregular aggregates, and the peptide tri-O-GlcNAcylated at all of Th72/Thr81/Ser87 did not aggregate at all.",
      "key": "0b0ea15822657b3184dfd2af6c76ef54",
      "line": 292,
      "relation": "causesNoChange",
      "source": 75,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An unmodified control, ASyn68-77, significantly accelerated wild-type aggregation while the GlcNAcylated analogue did not.",
      "key": "f8ce66bc874f969fbb52cde52f6fb3d0",
      "line": 299,
      "relation": "increases",
      "source": 69,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An unmodified control, ASyn68-77, significantly accelerated wild-type aggregation while the GlcNAcylated analogue did not.",
      "key": "ecfe788c2b1cd1af7c7a2c2e62ab3080",
      "line": 300,
      "relation": "increases",
      "source": 70,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "The authors suggested that OGlcNAcylation as studied in their case, had promoted oligomer-formation underlying the reduced aggregation",
      "key": "834065592cb0c5863a66965873469f29",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 12,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "25a9069ba939600903850788db3b21a1",
      "line": 343,
      "relation": "decreases",
      "source": 65,
      "target": 34
    },
    {
      "key": "75fb1da214d5023f483efc00fded00ff",
      "relation": "hasVariant",
      "source": 64,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "c02513d82fb70684c9906b28f5989b19",
      "line": 361,
      "relation": "increases",
      "source": 64,
      "subject": {
        "modifier": "Activity"
      },
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "725772ed5c3f0b47a961ce2d655d1e83",
      "line": 345,
      "relation": "decreases",
      "source": 49,
      "target": 34
    },
    {
      "key": "9dd8189a2b3a5de1bfa7880431999146",
      "relation": "hasVariant",
      "source": 48,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Zhang and co-workers found that OGA inhibition via acute Thiamet-G treatment promoted phosphorylation of mTOR and AKT, leading to decreased autophagic flux and subsequent accretion of dysfunctional ASyn",
      "key": "b6f8d6cf75f696d05801f942b66ca797",
      "line": 346,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 34,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "c8521fd2eb1035086d3d29092c864cd2",
      "line": 363,
      "relation": "decreases",
      "source": 34,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "3587536d1e089520320b440a95341df8",
      "line": 360,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent re-activation of autophagy via rapamycin, an mTOR inhibitor, attenuated the increase in ASyn accumulation also.",
      "key": "5cf0b87cf41a837466ddfba638567396",
      "line": 362,
      "relation": "decreases",
      "source": 5,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "902c4bb0bfe4e1167902410e0efa893f",
      "line": 376,
      "relation": "decreases",
      "source": 96,
      "subject": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Meanwhile, Vocadlo and co-workers reported that pharmacological inhibition of OGA, in each of neuroblastoma N2a cells, primary rat neurons, and a mouse brain, actually stimulates autophagy via an mTOR independent pathway",
      "key": "586e8a0e7120edca780f9875244b5c03",
      "line": 381,
      "relation": "decreases",
      "source": 106,
      "subject": {
        "modifier": "Activity"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Phosphorylation of tau regulates its modulatory functions by impairing its ability to bind microtubules.",
      "key": "a42b904d03d2daf91a467dcea3d59436",
      "line": 390,
      "relation": "decreases",
      "source": 61,
      "target": 37
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 57,
      "target": 61
    },
    {
      "key": "8b6b9bc97989061618adf5b808da8142",
      "relation": "partOf",
      "source": 57,
      "target": 37
    },
    {
      "key": "b5ef526ab5a17da51fd96bb875e02aac",
      "relation": "hasVariant",
      "source": 57,
      "target": 60
    },
    {
      "key": "2eff369575b4b0ea4c9252a5f852f9e1",
      "relation": "hasVariant",
      "source": 57,
      "target": 58
    },
    {
      "key": "1b5f06e5c4cba39182065536f402279a",
      "relation": "hasVariant",
      "source": 57,
      "target": 59
    },
    {
      "key": "13995767904f2c704ae2c85b287ed5eb",
      "relation": "hasVariant",
      "source": 57,
      "target": 63
    },
    {
      "key": "deebc6415a1d74c0501fe5fae6165d64",
      "relation": "hasVariant",
      "source": 57,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "1b0c340d37e595f4aaa86462c5d0a4ff",
      "line": 402,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 37,
      "target": 57
    },
    {
      "key": "927477822675564e953e78c2bcccd4b9",
      "relation": "partOf",
      "source": 17,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "3c50d16460f185cb19aa30b302548e65",
      "line": 401,
      "relation": "decreases",
      "source": 60,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "0aff71a24cbe769ed5d0a77492ca001e",
      "line": 403,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "f91f4d2e30a5069b6ebda342da5d9e4d",
      "line": 404,
      "relation": "increases",
      "source": 60,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Abnormal hyperphosphorylation of tau (P-tau) results in its detachment from microtubules, suppressing its activity and secondarily promoting its self-assembly into oligomers, ultimately giving rise to the NFTs present in the AD brain.",
      "key": "9055926008872207efb9a9117d158774",
      "line": 405,
      "relation": "increases",
      "source": 9,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "82c523bb566a5dba624d38668cc5fc65",
      "line": 447,
      "relation": "negativeCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Degradation"
      },
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "5d97b39589c74793e37cfc2a26e3753e",
      "line": 417,
      "relation": "negativeCorrelation",
      "source": 101,
      "target": 102
    },
    {
      "key": "2480a165e23542f322fd2d3c584e4520",
      "relation": "hasVariant",
      "source": 100,
      "target": 101
    },
    {
      "key": "81ac5169f532ac8d467f1682c518af63",
      "relation": "hasVariant",
      "source": 100,
      "target": 102
    },
    {
      "key": "c2bed5722d25b7c1f958c00d158f298c",
      "relation": "hasVariant",
      "source": 100,
      "target": 105
    },
    {
      "key": "ed55555352072f3e1817b02695fc04d6",
      "relation": "hasVariant",
      "source": 100,
      "target": 103
    },
    {
      "key": "57a924caa06187405ac84e29058dbf7c",
      "relation": "hasVariant",
      "source": 100,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "It was later found that tau phosphorylation was inversely regulated by OGlcNAc addition in vitro, in tissue culture cells, and ex vivo in rat brain slices (Figure 4)",
      "key": "1cf7b9d1bca1c79e769beabc80635832",
      "line": 417,
      "relation": "negativeCorrelation",
      "source": 102,
      "target": 101
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Furthermore, downregulation of OGT leads to increased tau phosphorylation and onset of AD pathology.",
      "key": "6ff4c9dcecf3d6d4d609b3060fde6a40",
      "line": 426,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 108,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, AD patient cortical brain tissues reportedly have significantly reduced levels of OGT expression compared to aged and post-mortem delay matched brain tissue.",
      "key": "2238f74787cd28716de3673a4d3ded0b",
      "line": 457,
      "relation": "decreases",
      "source": 108,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "afb094dfe5051443e11bf4ce244107ad",
      "line": 435,
      "relation": "negativeCorrelation",
      "source": 89,
      "target": 88
    },
    {
      "key": "d0260d683ca742c4ea3700a18197816c",
      "relation": "hasVariant",
      "source": 87,
      "target": 89
    },
    {
      "key": "896f2c68f697a7f961f96c39c9993355",
      "relation": "hasVariant",
      "source": 87,
      "target": 88
    },
    {
      "key": "d2678473e2fba5b74ed8f7c3edb2b279",
      "relation": "hasVariant",
      "source": 87,
      "target": 91
    },
    {
      "key": "ac46cce5d02d4aedb43857fecd2942b2",
      "relation": "hasVariant",
      "source": 87,
      "target": 95
    },
    {
      "key": "1a00ad5eb088a634f93a00acd0f57381",
      "relation": "hasVariant",
      "source": 87,
      "target": 92
    },
    {
      "key": "fd920c781f85788a41f03335c80091b2",
      "relation": "hasVariant",
      "source": 87,
      "target": 93
    },
    {
      "key": "39bcfcbc2f67ad951bc2c571b3010a0d",
      "relation": "hasVariant",
      "source": 87,
      "target": 94
    },
    {
      "key": "5dd6a708a892ff721c009091ebb1b773",
      "relation": "hasVariant",
      "source": 87,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Twelve-month old triple-tg mice (3xTg-Ad) displayed reduced levels of tau O-GlcNAcylation consistent with tau hyperphosphorylation in the hippocampus.",
      "key": "8d650699781f1d4408d8dc9cf9ebb511",
      "line": 435,
      "relation": "negativeCorrelation",
      "source": 88,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gong and co-workers identified that impaired brain glucose metabolism actually leads to neurofibrillary degeneration via downregulation of O-GlcNAcylation.",
      "key": "df5bf86379db86fd3be5b295cf03018c",
      "line": 446,
      "relation": "association",
      "source": 28,
      "target": 86
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "72ef1700413138b071389acae98b0b0d",
      "line": 464,
      "relation": "decreases",
      "source": 58,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Beyond inhibiting its phosphorylation, the O-GlcNAc modification hinders tau oligomerization",
      "key": "d99ad02cb7c41e8ae36785123d113596",
      "line": 465,
      "relation": "decreases",
      "source": 58,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Vocadlo and co-workers demonstrated that a recombinantly produced O-GlcNAc-modified tau construct (spanning residues 244- 441) formed oligomers at a slower rate, and to a lesser extent than the unmodified, recombinant control sequence during ThS fluorescence assays.",
      "key": "aa700e394f5f3399713e5cbe1264ed5c",
      "line": 473,
      "relation": "decreases",
      "source": 58,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Indeed, O-GlcNAc modification of tau-441 appeared to slow tauâs extension, perturbing the equilibrium position between oligomeric and free tau.",
      "key": "e13bdd8dc86a998a6116affe2e3ef88e",
      "line": 481,
      "relation": "decreases",
      "source": 42,
      "target": 9
    },
    {
      "key": "7b867af1455e9fd1be05e9be33cfc4d5",
      "relation": "hasVariant",
      "source": 41,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Results suggest O-GlcNAc modification at specifically Ser400 plays a critical role in hindering aggregation",
      "key": "054125cf4ebf7f89d9a94068c87b57e0",
      "line": 487,
      "relation": "decreases",
      "source": 59,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "7e522f31208aaf79d5a6a21f5b1878a8",
      "line": 577,
      "relation": "decreases",
      "source": 44,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Gazit, Segal and co-workers reported that their synthetic, O-GlcNAcylated PHF6 analogue, besides possessing reduced self-assembly propensity, seemed to inhibit unmodified PHF6 fibril formation upon co-incubation",
      "key": "54e27b8d4691f5b01eccd1f9a5b74be8",
      "line": 578,
      "relation": "decreases",
      "source": 44,
      "target": 8
    },
    {
      "key": "aeb7fed7d88ee1b7331516716a4c0ead",
      "relation": "hasVariant",
      "source": 43,
      "target": 44
    },
    {
      "key": "d27452e46263c87496a71903754fa081",
      "relation": "partOf",
      "source": 43,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "d60034206d2cca585b5465fd4e3c23d0",
      "line": 598,
      "relation": "negativeCorrelation",
      "source": 52,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "68e728e3c2ed23cd1b38a71fae36bc95",
      "line": 626,
      "object": {
        "location": {
          "name": "plasma membrane",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 52,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Subsequent work indicated that O-GlcNAcylation of APP promotes its plasma membrane localization, facilitating its non-amyloidogenic processing",
      "key": "e3772e40e90b505f74f5700438672874",
      "line": 627,
      "relation": "increases",
      "source": 52,
      "subject": {
        "location": {
          "name": "plasma membrane",
          "namespace": "GO"
        }
      },
      "target": 22
    },
    {
      "key": "f14c2ec769b5befa594b28e866672eaa",
      "relation": "hasVariant",
      "source": 50,
      "target": 52
    },
    {
      "key": "5efa9ea30f0b6cb4a55908d43e25d2ea",
      "relation": "hasVariant",
      "source": 50,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "An inverse correlation between O-GlcNAcylation and AÎ² formation was reported",
      "key": "be7c3f607b8d0cbc34e305cf3c149fb7",
      "line": 598,
      "relation": "negativeCorrelation",
      "source": 1,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "4ef9c11a409ae001db1a9c8e5ddc06b7",
      "line": 640,
      "relation": "association",
      "source": 1,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "3fdb38c190790397bebb8e149e43c29d",
      "line": 607,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "444dca0411a34d40320c9b0da07f9cfa",
      "line": 608,
      "relation": "decreases",
      "source": 18,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of the 5xFAD AÎ² mouse model with NButGT, another studied OGA inhibitor, impaired AÎ² production and attenuated activated gliosis",
      "key": "81435d9fed4c52ebdd6eb88c2bef4d05",
      "line": 609,
      "relation": "decreases",
      "source": 18,
      "target": 113
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spinal Cord": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Treatment of even the mSOD mice with an OGA inhibitor, NButGT, increased levels of O-GlcNAc in the spinal cord.",
      "key": "f97a015852d2c00eada189c7b9531015",
      "line": 713,
      "relation": "increases",
      "source": 18,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Thiamet-G treatment of tg TAPP (tau/APP) mice blocked cognitive decline paralleling decreased AÎ² and plaque levels while not affecting tau phosphorylation",
      "key": "613b342c3c06f7f0d2fc0a22f326ef58",
      "line": 640,
      "relation": "association",
      "source": 35,
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "feb3ad1dde6b5a2ca68a2b9076d68384",
      "line": 650,
      "relation": "regulates",
      "source": 2,
      "target": 116
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "cda84dc82fa0413552d9ce74d223e63a",
      "line": 651,
      "relation": "increases",
      "source": 2,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Finally, treatment with prostaglandin J2 (PGJ2), an endogenous mediator of inflammation that promotes cleavage of secreted APP, is reported to increase overall levels of protein O-GlcNAcylation.",
      "key": "f31a8fde2e3b1ba839868ba43453fa52",
      "line": 652,
      "relation": "increases",
      "source": 2,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "aad70f35f3c94464e3952412c58546f2",
      "line": 661,
      "relation": "association",
      "source": 54,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "3328c973b3562bba3637633589469f12",
      "line": 662,
      "relation": "association",
      "source": 54,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "587227369c8eef1774557f991d9c8d1a",
      "line": 663,
      "relation": "decreases",
      "source": 54,
      "target": 24
    },
    {
      "key": "0bbe5aca7e437c18e1f2944c9c2fcc48",
      "relation": "hasVariant",
      "source": 54,
      "target": 55
    },
    {
      "key": "1da06ba5d4294aa57b904f12e4eef0d5",
      "relation": "hasVariant",
      "source": 54,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "b2e9cd77e17ab77ed2ab0ae996bdfc5d",
      "line": 661,
      "relation": "association",
      "source": 33,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Normal huntingtin plays a role in vesicular transport, transcription of neuronal genes and production of brain-derived neurotrophic factor (BDNF), besides potentially also possessing some anti-apoptotic function.",
      "key": "9cbfe6708d3d60a091fe9c9fb3db6299",
      "line": 662,
      "relation": "association",
      "source": 53,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Instead, decreases in global O-GlcNAcylation levels is reported to be protective against huntingtin aggregation and cytotoxicity in neuroblastoma cells and fly models",
      "key": "e9283604dfdc47f7b7c37158b418daf7",
      "line": 670,
      "relation": "increases",
      "source": 55,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "6d17a7ff6de266e21bcfade7debfb0c6",
      "line": 678,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 55,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "f0462740aa720328d32277e60427f42a",
      "line": 676,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 55,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Decreasing O-GlcNAcylation enhances autophagosomelysosome function, which leads to increased basal autophagy flux and clearance of toxic huntingtin aggregates",
      "key": "aee4458bb61c2de1949ba30aa72f21d1",
      "line": 677,
      "relation": "decreases",
      "source": 55,
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spinal Cord": true
        },
        "MeSHDisease": {
          "Amyotrophic Lateral Sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Mice carrying a mutation in superoxide dismutase 1 (SOD1) also exhibit decreased OGlcNAc levels in the spinal cord",
      "key": "957cb72b9ec8da29af071b79ac41eb26",
      "line": 695,
      "relation": "decreases",
      "source": 99,
      "target": 98
    },
    {
      "key": "40881f33876372803b644a8b66131745",
      "relation": "hasVariant",
      "source": 97,
      "target": 99
    },
    {
      "key": "24b59ca35eaf6aa0b2c55658b457998f",
      "relation": "hasVariant",
      "source": 97,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Danon JJ",
          "Davey AK",
          "Kassiou M",
          "Mellick GD",
          "Rudrawar S",
          "Ryan P",
          "Xu M"
        ],
        "date": "2019-05-15",
        "db": "PubMed",
        "db_id": "30985105",
        "db_name": "O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.",
        "first": "Ryan P",
        "journal": "ACS chemical neuroscience",
        "last": "Rudrawar S",
        "pages": "2209-2221",
        "volume": "10"
      },
      "evidence": "Familial SOD1 mutations are responsible for 20% of familial ALS cases in humans",
      "key": "c472bbdadafce47781b26b565b5c259e",
      "line": 704,
      "relation": "increases",
      "source": 82,
      "target": 109
    },
    {
      "key": "1dd9720a67a0bafa7307ffc0f977ff98",
      "relation": "hasVariant",
      "source": 81,
      "target": 82
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin J2\")",
      "concept": {
        "name": "prostaglandin J2",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1ec0e20550eb3c2d2ac88e6b374d46f0"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "concept": {
        "name": "glucose",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "8b4d8974cf8c0e5830f78bb44168cf4d"
    },
    {
      "bel": "a(CHEBI:phospholipid)",
      "concept": {
        "name": "phospholipid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7519dbbdb0e794eb7a0963f4f33cfd42"
    },
    {
      "bel": "a(CHEBI:sirolimus)",
      "concept": {
        "name": "sirolimus",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "561f7408129243e1ed091f506ef0dded"
    },
    {
      "bel": "a(CONSO:\"Dopaminergic cell groups\")",
      "concept": {
        "name": "Dopaminergic cell groups",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "c6887492303fe16ab5c5e5b763561300"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "1b18e2b527ac0db7353b67d4534c033e"
    },
    {
      "bel": "a(CONSO:\"Tau oligomers\")",
      "concept": {
        "name": "Tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d45e1cc48bdfb58b4ead6900919dbbe3"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein aggregates\")",
      "concept": {
        "name": "alpha-synuclein aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "53fc23bd9119de24af4193a97807e463"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein fibrils\")",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "f5b5627dc21a2ebed276bedcb46eda96"
    },
    {
      "bel": "a(CONSO:\"alpha-synuclein oligomers\")",
      "concept": {
        "name": "alpha-synuclein oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "56edcb302ec17a7e26dafd6d02e279ad"
    },
    {
      "bel": "a(CONSO:\"huntingtin aggregates\")",
      "concept": {
        "name": "huntingtin aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "ddfb3dfcec37bcf8a1201a85c5723c38"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "274b01539a0746fbee06884b2af6c533"
    },
    {
      "bel": "a(GO:\"synaptic vesicle\")",
      "concept": {
        "name": "synaptic vesicle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "e01e57790c1fb1d6829181d1ed26fd86"
    },
    {
      "bel": "a(GO:autophagosome)",
      "concept": {
        "name": "autophagosome",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "ba5dcaa249a37bedb6b206d83ac47484"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(MESH:\"1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline\")",
      "concept": {
        "name": "1,2-dideoxy-2'-propylglucopyranoso(2,1-d)-delta 2'-thiazoline",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "aa78841fa286a20f0d700b12bc097bce"
    },
    {
      "bel": "a(MESH:Hexosaminidases)",
      "concept": {
        "name": "Hexosaminidases",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "2ac1a57052e739b1580c91790f2843f5"
    },
    {
      "bel": "a(PUBCHEM:135566354)",
      "concept": {
        "name": "135566354",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "b69ac4a46125f50c8cf6cefb257c5a29"
    },
    {
      "bel": "a(PUBCHEM:9576811)",
      "concept": {
        "name": "9576811",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "3c13f186cd3bf6b7a026183533649773"
    },
    {
      "bel": "bp(CONSO:\"APP processing\")",
      "concept": {
        "name": "APP processing",
        "namespace": "CONSO"
      },
      "function": "BiologicalProcess",
      "id": "d9c3ea10e4d58119f4b82eb7f80b3be2"
    },
    {
      "bel": "bp(GO:\"SNARE complex assembly\")",
      "concept": {
        "name": "SNARE complex assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "05b30e5bec54e53322cb72ef79a7b35f"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "concept": {
        "name": "apoptotic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9eb8739869ef0e82697f61a33d3d6afa"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"cellular glucose homeostasis\")",
      "concept": {
        "name": "cellular glucose homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "38d143426a53e4cd93f3f403a1f1c9f0"
    },
    {
      "bel": "bp(GO:\"dopamine secretion\")",
      "concept": {
        "name": "dopamine secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8373ee025bfe1eb5b0d4ba08e51b739"
    },
    {
      "bel": "bp(GO:\"glucose metabolic process\")",
      "concept": {
        "name": "glucose metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "57837c8bd480cd6e4257602591b12dac"
    },
    {
      "bel": "bp(GO:\"motor behavior\")",
      "concept": {
        "name": "motor behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a2dcc4ec00ebc4321e0089baccd16aa5"
    },
    {
      "bel": "bp(GO:\"musculoskeletal movement\")",
      "concept": {
        "name": "musculoskeletal movement",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a5b6cb847910da20f24ca34c9e69796c"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"protein phosphorylation\")",
      "concept": {
        "name": "protein phosphorylation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "d87820d546d1a4519930b54d5a68d801"
    },
    {
      "bel": "bp(GO:\"vesicle transport along microtubule\")",
      "concept": {
        "name": "vesicle transport along microtubule",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6939407599f79c53e5a5211c4947d7ec"
    },
    {
      "bel": "bp(GO:autophagy)",
      "concept": {
        "name": "autophagy",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "9efc965fac6a195d0fad26eecddaac05"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "complex(a(CHEBI:phospholipid), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "ec5500a7789b15340cb3ffc1025bf825",
      "members": [
        {
          "bel": "a(CHEBI:phospholipid)",
          "concept": {
            "name": "phospholipid",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "7519dbbdb0e794eb7a0963f4f33cfd42"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        }
      ]
    },
    {
      "bel": "complex(a(GO:microtubule), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "60e49c33ee1c6bbff236bae4989f16eb",
      "members": [
        {
          "bel": "a(GO:microtubule)",
          "concept": {
            "name": "microtubule",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "0fe6be9622e5650da7dca7cdced2f9db"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(CONSO:\"VQIVYK motif\"), p(CONSO:\"VQIVYK motif\"))",
      "function": "Complex",
      "id": "7d529cd123097dd1e5587a8d29b2c729",
      "members": [
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "concept": {
            "name": "VQIVYK motif",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "9b38965d99870547034625d1cd83bcfb"
        },
        {
          "bel": "p(CONSO:\"VQIVYK motif\")",
          "concept": {
            "name": "VQIVYK motif",
            "namespace": "CONSO"
          },
          "function": "Protein",
          "id": "9b38965d99870547034625d1cd83bcfb"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:SNCA))",
      "function": "Complex",
      "id": "c5827e439e158fd88cbc00efe1601ec9",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        },
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:SNCA), p(HGNC:VAMP2))",
      "function": "Complex",
      "id": "faa0b82962e3687e75e76379e023d2b7",
      "members": [
        {
          "bel": "p(HGNC:SNCA)",
          "concept": {
            "name": "SNCA",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "8cd39bc202ad944395c27f63d95f6908"
        },
        {
          "bel": "p(HGNC:VAMP2)",
          "concept": {
            "name": "VAMP2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "b4bb444c1610a72c1a48aa535f6320ac"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\")",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "83682de7856cc379117e146862b26202"
    },
    {
      "bel": "p(CONSO:\"Tau isoform F (441 aa)\", pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "Tau isoform F (441 aa)",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "bf5cbad008580d3dfa6819fd6165dbaa",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\")",
      "concept": {
        "name": "VQIVYK motif",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "9b38965d99870547034625d1cd83bcfb"
    },
    {
      "bel": "p(CONSO:\"VQIVYK motif\", pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "VQIVYK motif",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "d8341f37a3a803e3e7b01f64ed6bfdb0",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\")",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "ac4d837bea56b4618a658554b8c62c01"
    },
    {
      "bel": "p(CONSO:\"alpha-synuclein fibrils\", frag(\"?\"))",
      "concept": {
        "name": "alpha-synuclein fibrils",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "6b5e31823c508c1a9a028caa99b0868f",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(CONSO:\"sAPP-alpha\")",
      "concept": {
        "name": "sAPP-alpha",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "8846a5456d7a07582369bbaed50c87d7"
    },
    {
      "bel": "p(FPLX:AKT)",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "e0ada1edbf208bbaa7cb0798a2462eb3"
    },
    {
      "bel": "p(FPLX:AKT, pmod(Ph))",
      "concept": {
        "name": "AKT",
        "namespace": "FPLX"
      },
      "function": "Protein",
      "id": "4cd682f5a280ba91aeef5091781c4061",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP)",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d43ae551265c6b6a27038d0b036848cf"
    },
    {
      "bel": "p(HGNC:APP, frag(\"?\"))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1d7a8a2d778541f6083221fa6bb73dec",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "APP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "25cc9f0434584cc06f42213c6a99bc94",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:HTT)",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b06bc161685303d07e7b94f740920bb7"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5e04fb8e6f4e4c01dd22abc0b73ffd58",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:HTT, var(\"?\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "dd761e916586afccb5d4da7eda423ad0",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fbe2094c4bc18f55be4ef790e58f65a5",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:\"O-GlcNAcylation\", Ser, 400))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f019d6e8c43123cbd26759f8942b7658",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0d2d8072f03dcdf148e658067d37b9cb",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d20659abb6d812839958a31e9d5d259b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 231))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1b27e2cacb75475db2ede3bb5867066c",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(HGNC:MTOR)",
      "concept": {
        "name": "MTOR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a2450afd51fecb876f80e78722f0ba96"
    },
    {
      "bel": "p(HGNC:MTOR, pmod(Ph))",
      "concept": {
        "name": "MTOR",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7e2749731cd3670316f6510937579677",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:OGA)",
      "concept": {
        "name": "OGA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d4fa7628dcf93d39d434a1a4c6387ed9"
    },
    {
      "bel": "p(HGNC:OGT)",
      "concept": {
        "name": "OGT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "48d2a82c6bcb3e89526b69020087aa0d"
    },
    {
      "bel": "p(HGNC:SNCA)",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8cd39bc202ad944395c27f63d95f6908"
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"68_77\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "512ba283710cf73fdbddd67007e1987c",
      "variants": [
        {
          "kind": "frag",
          "start": 68,
          "stop": 77
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"68_77\"), pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a3fb609cf958d1da0390e07566327831",
      "variants": [
        {
          "kind": "frag",
          "start": 68,
          "stop": 77
        },
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "54870156ad22d51dacf6de81ed27ef3a",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, frag(\"?_*\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cac98388ccfeaaf3cee012d0b5f46f35",
      "variants": [
        {
          "kind": "frag",
          "start": "?",
          "stop": "*"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5c76c6238483838a4e4b56b75bb9a5fe",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Ser, 87))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "15cf97b64287f8cb8cebcc3f0f7194dd",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Ser, 87), pmod(CONSO:\"O-GlcNAcylation\", Thr, 72), pmod(CONSO:\"O-GlcNAcylation\", Thr, 81))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "841b2e442c90287e227dadc8462f5ca0",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 87
        },
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 72
        },
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 72))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e57f3ea370f297becd13b2560d1eb430",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 72
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 75))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9db4c92c1f8a82eafbc05ce9232097f3",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 75
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(CONSO:\"O-GlcNAcylation\", Thr, 81))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "59a79541d6f079f3b25ebe9d2a7d69dd",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod",
          "pos": 81
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, pmod(Ph))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f88647d4395590b0d65d44ad5f267262",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SNCA, var(\"?\"))",
      "concept": {
        "name": "SNCA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "937de1ef5af195c85dd0c5e0fb175d14",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:SOD1)",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "706116ed914ade77428db2dcc85fff62"
    },
    {
      "bel": "p(HGNC:SOD1, var(\"?\"))",
      "concept": {
        "name": "SOD1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "29935d28463e4877708f3bfe4b35cf23",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:VAMP2)",
      "concept": {
        "name": "VAMP2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b4bb444c1610a72c1a48aa535f6320ac"
    },
    {
      "bel": "p(HGNCGENEFAMILY:Calpains)",
      "concept": {
        "name": "Calpains",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "7ca722526fc0d17a88d8dc58f35706a6"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "p(MESH:Proteins, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "94db6fc7bd0d17f1c368072c8881cd4e",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a179f3829d42c3522d517c5ab2fc5b67"
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "80be6ed3b5d580a0c55f8902523d26ff",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(CONSO:hyperphosphorylation))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "f949656a30c3fadb71b0c12f1af31027",
      "variants": [
        {
          "concept": {
            "name": "hyperphosphorylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "27494583287536cfd1321001288923cd",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 202), pmod(Ph, Ser, 205))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "2d6f432762f5d6307e07c6dfce167c82",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 202
        },
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 205
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 356))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "871ff3fc8860eb95437f8bbc29bbff22",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 356
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "e3a6d720a297349ac7771d72afe8d616",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 400))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "9515fa5e04d97976e069665a1d80bcd4",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 400
        }
      ]
    },
    {
      "bel": "p(MGI:Mapt, pmod(Ph, Ser, 626))",
      "concept": {
        "name": "Mapt",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "bac0373b6cfc3a560bcde05e7509df9f",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 626
        }
      ]
    },
    {
      "bel": "p(MGI:Oga)",
      "concept": {
        "name": "Oga",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "9619f94595e73a908c1b5f5b8c36e3a0"
    },
    {
      "bel": "p(MGI:Sod1)",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "0ead17b7c5c4a222fe6f9167089950df"
    },
    {
      "bel": "p(MGI:Sod1, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "a1702b83a636e65349adeb5b912a36ab",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Sod1, var(\"?\"))",
      "concept": {
        "name": "Sod1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "112b035b0b82fe8c692ce15838d22924",
      "variants": [
        {
          "hgvs": "?",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt)",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "4491a7c731b98f8c5496132c49032c21"
    },
    {
      "bel": "p(RGD:Mapt, pmod(CONSO:\"O-GlcNAcylation\"))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "bdd87827b76071ba82d50d59a3f152a2",
      "variants": [
        {
          "concept": {
            "name": "O-GlcNAcylation",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "425f888fe9213332cada133bddf1a147",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "57d2a839b43a77b3666b3693ccb45477",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Ser, 422))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "d67dbbca9e22415c818cf899746a82b3",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 422
        }
      ]
    },
    {
      "bel": "p(RGD:Mapt, pmod(Ph, Thr, 231))",
      "concept": {
        "name": "Mapt",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "ba7c52b80bc032c82c8e66027ddd50b5",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 231
        }
      ]
    },
    {
      "bel": "p(RGD:Oga)",
      "concept": {
        "name": "Oga",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "6f0a5908fed909c2a489bd4f0f1655cc"
    },
    {
      "bel": "path(HP:\"Postural instability\")",
      "concept": {
        "name": "Postural instability",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "455cae0056b268ce7ad9d7b4fe9cfce5"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
      "concept": {
        "name": "Amyotrophic Lateral Sclerosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "73a119af95b8953eff6c1a96ee76f056"
    },
    {
      "bel": "path(MESH:\"Muscle Rigidity\")",
      "concept": {
        "name": "Muscle Rigidity",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6aef64b05afe13358b09ac1535703881"
    },
    {
      "bel": "path(MESH:\"Parkinson Disease\")",
      "concept": {
        "name": "Parkinson Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e45482025720b7db29c4fea458b4cae9"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:Gliosis)",
      "concept": {
        "name": "Gliosis",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "4662e4de5a80d3c9a0380007535e2195"
    },
    {
      "bel": "path(MESH:Hyperglycemia)",
      "concept": {
        "name": "Hyperglycemia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "434a44b2a5a2e5af4ba755a1b3825dec"
    },
    {
      "bel": "path(MESH:Hypokinesia)",
      "concept": {
        "name": "Hypokinesia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "205bfadff89a805493a4d7e958954c5f"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    }
  ]
}